Chromadex Corp (NASDAQ:CDXC) currently has a daily average trading volume of 1.30M but it saw 241199 shares traded in last market. With a market cap of 416.29M USD, the company’s current market price of $5.45 came rising about 0.93 while comparing to the previous closing price of $5.40. In past 52 weeks, the stock remained buoying in the range of price level as high as $7.97 and as low as $1.36. In the recent trading on the day, stock has struck highest price mark of $5.2801 while lowest mark touched by it was $5.478.
Taking a look at 20-day trading activity of Chromadex Corp (CDXC) gives us an average price of $5.71, while its current price level is -31.65% below from 52-week high level whereas it is 300.74% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $6.25 while that of 200 days or SMA-200 reads an average of $4.02. A closer look into the stock’s movement over the week reveals that its volatility is standing at 4.62% during that period while stretching the period over a month that increases to 5.19%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 39.95 which implies that the stock is in neutral territory.
B. Riley Securities downgraded its recommendation for the stock as a “Neutral” from “Buy” on August 11, 2022 while assigning a price target range of $6-$2.40. ROTH Capital issued its recommendations for the stock as it initiated the price target for the stock is $7.
Over the week, CDXC’s stock price is moving 2.73% up while it is -18.90% when we observe its performance for the past one month. Year-to-date it is 2.73% up and over the past year, the stock is showing an upside performance of 278.47%.
Currently, Chromadex Corp’s total number of outstanding shares is 76.03M. Company’s return on investment (ROI) stands at 4.10% and return on equity (ROE) at 4.82%. It has a price to earnings ratio (P/E ratio) of 288.36 while having a 41.13 of forward P/E ratio. Stock’s beta reads 2.21. Stock has a price to book (P/B) ratio of 12.06 while price to sale or P/S ratio amounts to 4.54. Its return on asset (ROA) is 2.70% on average.
